首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1439637

全球血液透析機市場：洞察、競爭格局、市場預測：2030 年

Haemodialysis Machines - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球血液透析設備市場規模為135.3億美元。預計到 2030 年，該市場將達到 177.8 億美元，2024 年至 2030 年的預測期間複合年增長率為 4.71%。血液透析機的需求增加主要是由於末期腎臟病和腎衰竭等腎臟疾病盛行率的上升。此外，老年人口的增長、高血壓和糖尿病盛行率的上升也是血液透析機的驅動因素，因為老年人和糖尿病患者更有可能患上腎臟疾病。此外，血液透析機產品線的技術進步和產品核准的增加也是推動2024-2030年預測期間全球血液透析機市場成長的因素之一。

由於多種原因，血液透析機市場的產品需求不斷增長，但影響血液透析機市場增長的主要因素之一是急性腎損傷和終末期腎病等腎臟疾病。相關疾病呈上升趨勢。

根據國際腎臟病學會 2022 年的數據，全球約有 1,330 萬例急性腎損傷 (AKI) 病例。在發展中國家，AKI 的負擔逐漸加重，估計每年有 1,130 萬人發病。

此外，代謝性酸中毒、電解質失衡、尿毒症等急性疾病也會增加對血液透析機的需求，因為這些疾病的患者需要透析。

此外，世界人口日益增加的糖尿病負擔也是導致血液透析機需求增加的因素。這是因為不受控制的糖尿病會幹擾腎臟清除體內廢物和多餘水分的能力。這種情況稱為糖尿病腎病變。

本報告檢視了全球血液透析設備市場，並提供了市場概述，包括按產品、最終用戶、地區和參與市場的公司概況劃分的趨勢。

Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Fresenius Medical Care
NIPRO
Baxter
Nikkiso Co., Ltd.
Perfect Medical Ind.Co., Ltd.
Browndove Healthcare (P) Ltd.
Advin Health Care
SWS Hemodialysis Care Co.,Ltd
Cantel Medical
Rockwell Medical, Inc.
Becton, Dickinson and Company
Dialife SA
Culligan
Mar Cor
Toray Medical Co,.Ltd.
Infomed SA
Guangdong Biolight Meditech
Trivitron Healthcare

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0474

Hemodialysis Machines Market By Product (Equipment [Hemodialysis Machines, Haemodialysis Water Treatment Systems, Others], Consumables & Supplies [Dialyzers, Hemodialysis Concentrates/Dialysates, Hemodialysis Access Products, Catheters, Bloodlines Sets And Tubes, Others]), By End-User (Independent Dialysis Centers, Home Care Settings), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of kidney disorders and rapid technological developmental activities in product arena

Global Hemodialysis Machines market was valued at USD 13.53 billion in 2023, growing at a CAGR of 4.71% during the forecast period from 2024 to 2030 to reach USD 17.78 billion by 2030. The increase in demand for Hemodialysis Machines is primarily attributed to the increasing prevalence of kidney disorders such as end-stage kidney disorder, kidney failure, and others. In addition constantly increasing old population, high blood pressure, and high diabetes prevalence is also driving factor for Hemodialysis Machines as old age and diabetic people are more likely to develop kidney disorders. Moreover, technological advancement in the Hemodialysis Machines product pipeline and an increase in product approvals are among the other factors responsible for the growth of the global Hemodialysis Machines market during the forecast period from 2024 to 2030.

Hemodialysis Machines Market Dynamics:

The Hemodialysis Machines market is witnessing a growth in product demand owing to various reasons, one of the major factors influencing the growth of the Hemodialysis Machines market is the rising prevalence of kidney-associated disorders such as acute kidney injury, and end-stage renal disorders, among others, worldwide.

According to the International Society of Nephrology 2022, there are around 13.3 million cases of acute kidney injury (AKI) worldwide. The burden of AKI is gradually increasing in developing countries with an estimated annual incidence of 11.3 million.

Furthermore, acute conditions such as metabolic acidosis, electrolyte imbalance, and uremia, among others could also raise the demand for Hemodialysis Machines as dialysis is needed by the patients suffering from these conditions.

In addition, the rising burden of diabetes among the population across the globe is also a factor that would lead to the increase in demand for Hemodialysis Machines. This is because uncontrolled diabetes hampers the kidney's ability to remove waste products and excessive fluids from the body. This situation is known as diabetic nephropathy.

As per the International Diabetes Federation (IDF) 2020 statistics, in the year 2019, approximately 463 million adult population in the world were living with diabetes which is estimated to shoot up to 700 million by the end of the year 2045.

Also, as per the IDF 2022 stats, the world's more than 80% of end-stage renal disorders (ESRD) are caused due to diabetes, hypertension, or a combination of both. Therefore, rising unmanageable diabetes can be a potential factor contributing to the Hemodialysis Machines market growth.

Additionally, the major advantages associated with Hemodialyses such as the reduced frequency of visits to a dialysis center, use of the Hemodialysis Machines at home by the patients without any assistance, and fewer restriction on intake of diet and fluid and others are likely to surge the demand for Hemodialysis Machines among the target population thereby propelling the global market for Hemodialysis Machines.

Henceforth, all the above-mentioned factors will contribute to the global Hemodialysis Machines market growth during the forecast period.

In addition, the unprecedented COVID-19 pandemic currently presents a variety of challenges for clinical healthcare providers and patients around the world. The increase in the number of COVID cases along with the increase in severity is likely to lead to a potential increase in the incidence of kidney damage. Due to the pandemic, the need for kidney replacement fluids has increased significantly around the world. According to the American Society of Nephrology 2022, in the pre-COVID-19 era, 23,105 patients were treated for AKI with renal replacement therapy annually in 2018, whereas the demand for renal replacement therapy in patients with COVID-19 has increased to 4.9% in 2020 from 0.9% before the pandemic. The gradual shift towards home Hemodialysis Machines to curb the spread of COVID-19 infection has greatly accelerated patient interest in treating kidney disorders at home. This factor is likely to drive the adoption of Hemodialysis Machines products during the pandemic.

However, the risk and complications associated and the high cost of Hemodialysis Machines may be certain limiting factors to the Hemodialysis Machines market growth.

Hemodialysis Machines Market Segment Analysis:

Hemodialysis Machines Market By Product (Equipment [Hemodialysis Machines, Haemodialysis Water Treatment Systems, Others], Consumables & Supplies [Dialyzers, Hemodialysis Concentrates/Dialysates, Hemodialysis Access Products, Catheters, Bloodlines Sets and tubes, Others]), By End-User (Independent Dialysis Centers, Home Care Settings), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product segment of the Hemodialysis Machines market, the Hemodialysis Machines are estimated to hold a significant share in the Hemodialysis Machines market during the forecast period from 2024 to 2030. This can be attributed to the prevalence of kidney disorders such as end-stage kidney disorder, and kidney failure across the globe. For instance, according to National Kidney Foundation Inc., 2022 report, 1 in 3 adults in the US (approximately 80 million) is at risk for kidney disease. Kidney disease is more common in women (14%) than men (12%). But for every 2 women who develop end-stage kidney disease (ESKD), 3 men's kidneys fail. Kidney disease is a leading cause of death in the US.

Hemodialysis Machines enable patients to improve patients quality of life by giving them freedom from acute kidney diseases. Moreover, key players are actively involved in the manufacturing of these machines.

In addition, rising research and development to produce technologically advanced Hemodialysis Machines products could also lead to market growth of Hemodialysis Machines.

Moreover, recent product approvals of Hemodialysis Machines are also expected to spur the market for Hemodialysis Machines. For instance, in April 2020, the FDA approved Outset Medical's Tablo Hemodialysis Machines System for use in a home setting after positive results from 30 patients who completed a year-long trial.

Hence, all the above-mentioned factors will lead to the segmental growth of the Hemodialysis

Machines market in the coming years.

Thus, all the aforementioned factors are likely to propel the Hemodialysis Machines category growth in the Hemodialysis Machines market during the forecast period.

North America is expected to dominate the overall Hemodialysis Machines Market:

Among all the regions, North America is expected to account for the largest share of the global Hemodialysis Machines market. This domination is due to the increasing population suffering from renal disorders, the presence of a well-established healthcare expenditure system for people suffering from ESRD, the gaining popularity of cost-effective and portable dialysis machines for home care settings, and government initiatives towards better management of renal diseases, among others. The Advancing American Kidney Health launched by the Trump administration in the year 2019 is an initiative to raise the adoption of home dialysis and kidney transplantation to 80% of the incident population receiving kidney replacement therapy by 2025.

Further, in the United States, the rising cases of ESRD in the region along with the patient pool shifting towards the at-home Hemodialysis Machines is anticipated to augment the Hemodialysis Machines equipment market in the region. For instance, as per the United States Renal Data System Annual report 2020, the population suffering from ESRD in the region was around 131,636.

Moreover, elevated cases of hypertension among the US population which is a second leading cause of developing kidney malfunction after diabetes is also a factor likely to boost the demand for Hemodialysis Machines. According to the Centers for Disease Control and Prevention 2022 data, in the year 2019, an estimated 47%, or 116 million had hypertension.

Also, as per the National Kidney Foundation Inc. 2022, about 37 million Americans were suffering from chronic kidney disorder (CKD) in the region. Thus, rising renal disorders and other comorbidities such as hypertension and diabetes will contribute to the market growth for Hemodialysis Machines.

In addition, recent product approval by the US Food and Drug Administration (FDA) for Hemodialysis Machines will also boost the market for Hemodialysis Machines in the region.

Hence all the aforementioned factors are responsible for contributing to the growth of the Hemodialysis Machines market in the region.

Hemodialysis Machines Market Key Players:

Some of the key market players operating in the Hemodialysis Machines market include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Fresenius Medical Care, NIPRO, Baxter, Nikkiso Co., Ltd., Perfect Medical Ind.Co., Ltd., Browndove Healthcare (P) Ltd., Advin Health Care, SWS Hemodialysis Care Co., Ltd, Cantel Medical, Rockwell Medical, Inc., Becton, Dickinson and Company, Dialife SA, Culligan, Mar Cor, Toray Medical Co, Ltd., Infomed SA, Guangdong Biolight Meditech, Trivitron Healthcare, and others.

Recent Developmental Activities in the Hemodialysis Machines Market:

On February 23, 2022, the FDA approved Difelikefalin injection (Korsuva; Cara Therapeutics and Vifor Pharma) for the treatment of moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP) in adults undergoing Hemodialysis (HD).

On November 29, 2022, Outset Medical, Inc., a medical technology company reducing the cost and complexity of dialysis, announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for a new sterilization method of the cartridge utilized in its Tablo® Hemodialysis System, enabling full production in North America.

Key Takeaways from the Hemodialysis Machines Market Report Study

Market size analysis for current Hemodialysis Machines market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Hemodialysis Machines market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened in the last 3 years
Key companies dominating the global Hemodialysis Machines market.
Various opportunities available for the other competitor in the Hemodialysis Machines market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current Hemodialysis Machines market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Hemodialysis Machines market growth in the coming future?

Target Audience who can be benefited from this Hemodialysis Machines Market Report Study

Hemodialysis Machines products providers
Research organizations and consulting companies
Hemodialysis Machines-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Hemodialysis Machines
Various End-users want to know more about the Hemodialysis Machines market and the latest technological developments in the Hemodialysis Machines market.

Frequently Asked Questions for the Hemodialysis Machines Market:

1. What is Hemodialysis Machines?

In Hemodialysis Machines, a machine filters wastes, salts, and fluid from the blood when the kidneys are no longer healthy enough to do this work adequately. Hemodialysis Machines is one way to treat advanced kidney failure and can help carry on an active life despite failing kidneys.

2. What is the market for Global Hemodialysis Machines?

Global Hemodialysis Machines Market was valued at USD 13.53 billion in 2023, growing at a CAGR of 4.71% during the forecast period from 2024 to 2030 to reach USD 17.78 billion by 2030.

3. What are the drivers for Global Hemodialysis Machines Market?

The Hemodialysis Machines market is witnessing a positive market growth owing to the increase in demand for Hemodialysis Machines is primarily attributed to the increasing prevalence of kidney disorders such as end-stage kidney disorder, kidney failure, and others. In addition constantly increasing old population, high blood pressure, and high diabetes prevalence is also driving factor for Hemodialysis Machines as old age and diabetic people are more likely to develop kidney disorders. Moreover, technological advancement in the Hemodialysis Machines product pipeline and an increase in product approvals are among others.

4. Who are the key players operating in the Global Hemodialysis Machines Market?

5. Which region has the highest share in Hemodialysis Machines Market?

North America is expected to hold the highest share of the revenue in the Hemodialysis Machines market during the forecast period. This domination is due to the increasing population suffering from renal disorders, the presence of a well-established healthcare expenditure system for people suffering from ESRD, the gaining popularity of cost-effective and portable dialysis machines for home care settings, and government initiatives towards better management of renal diseases, among others.

1.Hemodialysis Machines Market Report Introduction

2.Hemodialysis Machines Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Hemodialysis Machines Market Key Factors Analysis

4.1. Hemodialysis Machines Market Drivers
- 4.1.1. Increasing Prevalence of Kidney Disorders
- 4.1.2. Increasing Old Population
- 4.1.3. Technological Advancement in the Hemodialysis Machines Product Pipeline
- 4.1.4. Rising Prevalence of Diabetes and Hypertension
4.2. Hemodialysis Machines Market Restraints and Challenges
- 4.2.1. Risks and associated Complications
- 4.2.2. High Cost of the Hemodialysis Machines
4.3. Hemodialysis Machines Market Opportunities
- 4.3.1. Rising Popularity of At-Home Hemodialysis Machines Product
- 4.3.2. Targeting Emerging Markets for Product Launches

5. Hemodialysis Machines Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Hemodialysis Machines Market

7. Hemodialysis Machines Market Layout

7.1. By Product
- 7.1.1. Equipment
  - 7.1.1.1. Hemodialysis Machines
  - 7.1.1.2. Haemodialysis Water Treatment Systems
  - 7.1.1.3. Others
- 7.1.2. Consumables & Supplies
  - 7.1.2.1. Dialyzers
  - 7.1.2.2. Hemodialysis Concentrates/Dialysates
  - 7.1.2.3. Hemodialysis Access Products
  - 7.1.2.4. Catheters
  - 7.1.2.5. Bloodlines Sets and tubes
  - 7.1.2.6. Others
7.2. By End User
- 7.2.1. Independent Dialysis Centers
- 7.2.2. Home Care Settings
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. North America Hemodialysis Machines Market, by Product
  - 7.3.1.2. North America Hemodialysis Machines Market, by End User
  - 7.3.1.3. North America Hemodialysis Machines Market, by Country
  - 7.3.1.3.1. United States
  - 7.3.1.3.2. Canada
  - 7.3.1.3.3. Mexico
- 7.3.2. Europe
  - 7.3.2.1. Europe Hemodialysis Machines Market, by Product
  - 7.3.2.2. Europe Hemodialysis Machines Market, by End User
  - 7.3.2.3. Europe Hemodialysis Machines Market, by Country
  - 7.3.2.3.1. France
  - 7.3.2.3.2. Germany
  - 7.3.2.3.3. United Kingdom
  - 7.3.2.3.4. Italy
  - 7.3.2.3.5. Spain
  - 7.3.2.3.6. Russia
  - 7.3.2.3.7. Rest of Europe
- 7.3.3. Asia-Pacific
  - 7.3.3.1. Asia-Pacific Hemodialysis Machines Market, by Product
  - 7.3.3.2. Asia-Pacific Hemodialysis Machines Market, by End User
  - 7.3.3.3. Asia-Pacific Hemodialysis Machines Market, by Country
  - 7.3.3.3.1. China
  - 7.3.3.3.2. Japan
  - 7.3.3.3.3. India
  - 7.3.3.3.4. Australia
  - 7.3.3.3.5. South Korea
  - 7.3.3.3.6. Rest of Asia Pacific
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. RoW Hemodialysis Machines Market, by Product
  - 7.3.4.2. RoW Hemodialysis Machines Market, by End User
  - 7.3.4.3. RoW Hemodialysis Machines Market, by Region
  - 7.3.4.3.1. Middle East
  - 7.3.4.3.2. Africa
  - 7.3.4.3.3. South America

8. Hemodialysis Machines Market Global Company Share Analysis - Key 3-5 Companies

9. Hemodialysis Machines Market Company and Product Profiles

9.1. Asahi Kasei Medical Co., Ltd.
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. B. Braun Melsungen AG
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. Fresenius Medical Care
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. NIPRO
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. Baxter
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Nikkiso Co., Ltd.
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. Perfect Medical Ind.Co., Ltd.
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Browndove Healthcare (P) Ltd.
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Advin Health Care
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. SWS Hemodialysis Care Co.,Ltd
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Cantel Medical
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Rockwell Medical, Inc.
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. Becton, Dickinson and Company
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Dialife SA
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. Culligan
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Mar Cor
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Toray Medical Co,.Ltd.
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. Infomed SA
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Guangdong Biolight Meditech
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. Trivitron Healthcare
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy